All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HCV Infection-24100495
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24100495 A156F
NS3-4A
NS3-4A
HCV Infection
D
View
2 24100495 A156N
NS3-4A
NS3-4A
HCV Infection
D
View
3 24100495 A156S
NS3-4A
NS3-4A
HCV Infection
D
View
4 24100495 A156T
NS3-4A
NS3-4A
HCV Infection
D
View
5 24100495 A156V
NS3-4A
NS3-4A
HCV Infection
D
View
6 24100495 D168N
NS3-4A
NS3-4A
HCV Infection
D
View
7 24100495 I132V
NS3-4A
NS3-4A
HCV Infection
D
View
8 24100495 R155G
NS3-4A
NS3-4A
HCV Infection
D
View
9 24100495 R155I
NS3-4A
NS3-4A
HCV Infection
D
View
10 24100495 R155K
NS3-4A
NS3-4A
HCV Infection
D
View
11 24100495 R155M
NS3-4A
NS3-4A
HCV Infection
D
View
12 24100495 R155S
NS3-4A
NS3-4A
HCV Infection
D
View
13 24100495 R155T
NS3-4A
NS3-4A
HCV Infection
D
View
14 24100495 T54A
NS3-4A
NS3-4A
HCV Infection
D
View
15 24100495 T54S
NS3-4A
NS3-4A
HCV Infection
D
View
16 24100495 V36A
NS3-4A
NS3-4A
HCV Infection
D
View
17 24100495 V36C
NS3-4A
NS3-4A
HCV Infection
D
View
18 24100495 V36G
NS3-4A
NS3-4A
HCV Infection
D
View
19 24100495 V36I
NS3-4A
NS3-4A
HCV Infection
D
View
20 24100495 V36L
NS3-4A
NS3-4A
HCV Infection
D
View
21 24100495 V36M
NS3-4A
NS3-4A
HCV Infection
D
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.